Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
The Scientist
Most Recent
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
A neurodegenerative disease researcher found guilty of fabricating results in funding applications has written an open letter of apology and clarification.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
An NIH study finds that the former NFL linebacker who committed suicide last May had signs of degenerative brain disease.
Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.
A new ethics course aims to rehabilitate scientists found guilty of misconduct so they can return to the field as productive researchers.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
